ClinicalTrials.Veeva

Menu

DNA Methylation and Urothelial Carcinoma

C

China Medical University

Status

Unknown

Conditions

Urothelial Carcinoma

Study type

Observational

Funder types

Other

Identifiers

NCT01378052
DMR100-IRB-092

Details and patient eligibility

About

Many studies previously showed the significant association between urinary arsenic profiles and urothelial carcinoma (UC) risk and observed the increased UC risk in people with lower plasma folate and higher homocysteine than those with higher plasma folate and lower homocysteine. The investigators would expect to explore the interactions among global DNA methylation, one-carbon metabolic pathway factors, urinary arsenic profiles and UC.

Enrollment

200 estimated patients

Sex

All

Ages

21+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of urothelial carcinoma
  • The voluntary of participating the study

Exclusion criteria

  • Age smaller than 20 years
  • Pregnant women
  • Not willing to participate the study because of their personal reasons

Trial design

200 participants in 2 patient groups

urothelial carcinoma pateints
healthy controls
Description:
Age and gender matched control subjects with no evidence of UC or any other malignancy were accrued from the hospital, recruiting people receiving adult health examinations at China Medical University Hospital.

Trial contacts and locations

1

Loading...

Central trial contact

Chao-Hsiang Chang, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems